Introduction: Aging as a Multidetermined Process-The Phenotype Concept
Comorbid Aging/HIV and Cognitive Aging/HIV: Defining and Characterizing
Phenotype | Definition | Illustrative HIV study |
---|---|---|
Disability | Dependency or difficulty in carrying out activities essential to independent living | Avila-Funes et al. 2016 [10] |
Frailty | Physiologic state of increased vulnerability to stressors | Gustafson et al. 2016 [11] |
Comorbid aging | Concurrent presence of two or more medically diagnosed diseases in the same person | Rodriguez-Penney et al. 2013 [12] |
Cognitive aging | Continuum of cognitive decline across domains of information processing speed, episodic and working memory, attention, abstraction/executive function, motor function, visuospatial function, and language | Fazeli et al. 2014 [13] |
Premature or accelerated aging | Conditions associated with aging process that occur at an earlier age or may involve high life stressor burden, lack of social support, and/or maladaptive coping strategies | Sheppard et al. 2017 [14] |
Successful aging | Characterized by subjective well-being and satisfaction with life, associated with resilience and other positive traits. | Moore et al. 2013 [15] |
Other Aging Phenotypes in HIV Infection
Phenotypic Inter-Relationships: Comorbid Aging/HIV and Cognitive Aging/HIV
Comorbid aging with cognitive aging: Correlative Relationships | Older HIV-infected Sample | Study |
Neuropsychiatric symptoms (psychiatric symptom burden using Geriatric Depression Scale and Neuropsychiatric Inventory Questionnaire) not associated with cognitive functioning (HAND, Clinical Dementia Rating) | Older (> 60 years) HIV infected adults from community | Milanini et al. 2017 [52] |
Increasing number of medical comorbidities (most common hyperlipidemia, hypertension, peripheral neuropathy) associated with increasing risk of having more geriatric syndromes (among cognitive and functional impairment, depression, falls, frailty, sensory impairment) | Older (> 50 years) HIV negative infected adults | Greene et al. 2015 [53] |
Comorbid medical disorders (i.e., hypertension, stroke) associated with lower performing cognitive subtype (processing speed), more prominent in older adults, but not with normal performing cognitive subtype | HIV-infected adults and older adults (mean age 46.1 yrs) | Fazeli et al. 2014 [13] |
Comorbidities (diabetes most prevalent) associated with global and syndromic neuropsychological impairment (interfering with daily functioning) in older group | Older (≥ 50 years) and younger (≤ 40 years) HIV-infected and uninfected from community | Rodriguez-Penney 2013 [12] |
Depressive symptoms (Beck Depression Inventory) associated with poorer selective cognitive (motor speed visuospatial memory) and life functioning (quality of life) | Middle aged men and women HIV infected (43.9 years mean age) | Sassoon et al. 2012 [54] |
Depressive symptoms (Beck Depression Inventory) associated with neuropsychological impairment in younger but not in older adults | HIV infected older adults (< 50 years) from Hawaii Aging with HIV Cohort and HIV infected younger adults (20–39 years) | Shimizu et al. 2011 [55] |
Cardiovascular comorbidities (carotid disease) associated with some measures of cognitive impairment (Stroop interference) | Middle aged women (early 40s) from WIHS | Crystal et al. 2011 [56] |
Increasing degree insulin resistance associated with lower cognitive performance (neuropsychological summary scores), especially in middle-aged and older subgroup | Middle-aged and older (> 50 years) participants from Hawaii Aging HIV Cohort | Valcour et al. 2006 [57] |
Increased depressive symptoms associated with increased self-reported memory problems | HIV positive veterans in care (< 50 years) from Veterans Aging Cohort Five-Site Study | Justice et al. 2004 [28] |
Comorbid aging with cognitive aging: Temporal Relationships | Older HIV-infected sample | Study |
Comorbidity risk factors (stimulant use, vascular disease, hepatitis C, HIV disease severity, cognitive reserve) predict cognitive functioning (learning/memory, verbal fluency); cognitive reserve strongest predictor of neurocognition; impact on learning/memory and verbal fluency in older and in younger adults linked to working memory and executive function | HIV infected older adults (> 50 years) on HAART, recruited from community | Patel et al. 2013 [58] |
Depression was strongest predictor of cognitive functioning; those with higher levels of depressive symptomatology experienced poorer cognitive functioning. | HIV-infected, community-dwelling older adults (mean age 75 years) | Vance et al. 2005 [59] |
Comorbid aging with frailty relationships: Correlative Relationships | Older HIV-infected sample | Study |
Aging related chronic diseases and comorbidities (e.g., hypertension, diabetes, cancer) associated with HIV infection related sociodemographic factors and health behaviors | Middle-aged women living with HIV from the WIHS cohort | Gustafson et al. 2016 [11] |
Multiple chronic medical conditions, depression symptoms, and inflammatory index associated with frailty (Fried phenotype criteria); inflammatory index independently associated with frailty and mortality risk among older infected and noninfected injection drug users | Hopkins ALIVE cohort (Median age 47 yrs., 29% HIV infected) | Pigott et al. 2015 [60] |
Medical comorbidities/depression and adverse health outcomes (hospitilization/mortality) associated with frailty and with risk for hospitilization | HIV infected and uninfected from Veteran Administration Cohort Study, VACS (40–60 years) | Akgun et al. 2014 [61] |
Hepatitis C seropositivity, history of AIDS-defining-illness, and greater depressive symptoms more likely to be associated with pre-frail/frail participants | Observational cohort of HIV-infected persons (median age 47 yrs), 95% on cART | Onen et al. 2014 [62] |
Most common comorbidities were hypertension (60%) and those with a history of AIDS-related opportunistic infections; comorbidities, cognitive impairment more prevalent in severely frail | Frail older (> 60 years) patients in three groups (mildly, moderately, severely frail) | Ruiz and Cefalu 2011 [63] |
Comorbid aging with frailty Relationships: Correlative Relationships | Older HIV-infected sample | Study |
Medical comorbidities predict frailty with the strongest predictability for hepatitis C infection, depressive symptoms, history of diabetes, and kidney disease (in decreasing order of predictability); sizable proportion of HIV+ and HIV- men had positive frailty status suggesting comorbidities and frailty are not synonymous | HIV-infected MSM (men who have sex with men) from MACS (Multicenter AIDS Cohort Study) (median age 53.8 yrs); 84% on HAART) | Althoff et al. 2014 [64] |
Comorbid aging with disability: Correlative Relationships | Older HIV-infected sample | Study |
Increased number of chronic diseases (dyslipidemia 57%, and hypertension 33%, most frequent), age, VL and CD4 count were independently associated with both types of disability (basic and instrumental activities of daily living) | HIV infected older adults (mean age, 59.3 years) receiving ambulatory care in HIV clinic Mexico | Avila-Funes et al. 2016 [10] |
Depression and sleep problems strongly associated with WHO disability assessment scores (domains of cognition, mobility, self care, getting along, life activities, participation) | HIV-infected older adults (mean age, 65 years) from Uganda | Mugisha et al. 2016 [65] |
Pain independently associated with substantially increased odds of impairment in three domains of physical function (mobility, self care, usual activities) | HIV-infected middle aged adults (median age, 43.6 years); outpatients | Merlin et al. 2013 [66] |
Medical comorbidities (Charlson) independently associated with physical (and mental) health related quality of life | Older (≥ 50 years) and younger (≤ 40 years) HIV-infected and uninfected from community | Rodriguez-Penney et al. 2013 [12] |
Major depression, chronic lung disease, coronary artery disease, hypertension, smoking independently associated with reduced physical function (i.e., comorbidities account for relationship between increased age and reduced physical function in both infected and uninfected) | HIV-infected adults from VACS (< 40, 40–69, 60–59, and > 60 years) | Oursler et al. 2006 [67] |
Comorbid aging with accelerated aging relationships: Correlative Relationships | Older HIV-infected sample | Study |
Prevalence of two or more non-infectious comorbidities (among diabetes mellitus, cardiovascular disease, bone fractures, and renal failure) similar in HIV-infected patients aged 41–50 years and uninfected persons 51–60 years | HIV-infected and uninfected adults from Italy (< 40, 41–50, 51–60, and > 60 years) | Guaraldi et al. 2011 [68] |
Non-AIDS defining cancers (anal, colon) diagnosed in significantly younger persons (by about 20 yrs) with AIDS than expected in the general population | Persons with AIDS in the U.S. population-based HIV/AIDS Cancer Match Registry (restricted to age-at-diagnosis distributions 4–60 months after AIDS diagnosis) | Shiels et al. 2010 [69] |
Cognitive aging with frailty relationships: Correlative Relationships | Older HIV-infected sample | Study |
Cognitive impairment (47%), difficulty with instrumental activities of daily living (46%) and prefrailty (56%) most frequent geriatric syndromes; also experienced at younger ages | HIV-infected adults on HAART (median age, 57 years) | Greene et al. 2015 [53] |
Trend toward lower memory functioning (but not executive function, speed of processing, motor skills), together with decreased grip strength in older adults (> 50 years); comorbid depression did not differ between older and younger groups | Small groups of older (mean age, 56.5 years) and younger (mean age, 31.5 years) HIV-infected adults) | Sandkovsky et al. 2013 [70] |
Many cognitive domains (such as verbal and visual memory, visual perception, and language) significantly related to aerobic fitness; More severe forms of HIV-associated neurocognitive disorders (HAND) such as mild neurocognitive disorder and HIV-associated dementia associated with reduced likelihood of higher aerobic fitness | HIV-infected adults (mean age, 58.9 years) on HAART from infectious disease clinic | Mapstone et al. 2013 [71] |
Cognitive aging with disability: Correlative Relationships | Older HIV-infected sample | Study |
Reduced speed of processing associated with poorer everyday functioning in HIV infected older adults; chronicity of HIV infection had stronger relationship with poorer speed of processing than with poorer everyday functioning | Older (mean age, 57 years) and younger (mean age, 42 years) HIV infected and uninfected adults | Vance et al. (2013) [72] |
Most cognitive measures (e.g., trail making, finger tapping, letter and pattern comparison, digit span) associated with poorer performance on instrumental activities of daily living | Older (mean age, 45 years) and younger (mean age, 38 years) infected and uninfected adults recruited from community | Vance et al. (2011) [73] |
Cognitive aging with accelerated aging: Correlative Relationships | Older HIV-infected sample | Study |
Auditory attention of older HIV+ adults impaired relative to age matched seronegative adults (accentuated aging) and impaired to same degree as age matched seronegative adults in their 70’s (accelerated aging); no association with memory, language, or speeded executive functions. | Older HIV-infected and uninfected adults (aged > 65 years and from 50 to 65 years) | Sheppard et al. 2017 [14] |
HIV-associated neurocognitive disorder, HAND, diagnoses associated with accelerated epigenetic aging (average relative acceleration of 3.5 years) in post-mortem brain tissue (occipital cortex); age acceleration not correlated with pre-mortem neurocognitive functioning or HAND severity | Patients with HAND and neurologically normal (mean age, 48.5 years at death) | Levine et al. 2016 [74] |
HIV-associated neurocognitive disorder, HAND, and neurocognitive impairment scores (global and domains motor, memory encoding and retrieval, executive function) with alterations in CSF metabolites (glutamate, NAA), plasma inflammatory biomarkers associated with advanced age | CSF analyses of older (> 50 years) and younger (< 50 years) infected and uninfected adults from National NeuroAIDS Tissue Consortium, NNTC | Cassol et al. 2014 [75] |
Age-related metabolic changes affecting cardiovascular risk hypertension) predispose to neurocognitive decline (psychomotor speed) through accelerated cerebrovascular disease | Middle-aged (40 years) adults HIV infected and uninfected, from Multicenter AIDS Cohort Study, MACS, cardiovascular and cerebrovascular disease substudy | Becker et al. 2009 [76] |
Cognitive aging with successful aging: Correlative Relationships | Older HIV-infected sample | Study |
One third of older persons with HIV free of cognitive impairments on battery of validated cognitive tests (also had better everyday functioning and fewer medical and psychiatric comorbidities) | Middle-aged and older persons (mean age 51 years) infected with HIV | Malaspina et al. 2011 [77] |
Interventions Targeting Aging/HIV-Related Phenotypes
Summary and Directions
Approach | Research aims/questions |
---|---|
Clinical and behavioral specification
| 1. Identify differentiating characteristics and determinants of HIV/aging phenotypes; |
2. Examine impact of specific components for a given HIV-related aging phenotype on dysfunctions; | |
3. Identify distinctive phenotypic clusters for improved clinical and diagnostic assessment between and within HIV-related aging phenotypes and facilitate development of targeted remediation and compensatory interventions; | |
4. Predict prognosis and treatment outcomes for HIV-related aging phenotypes | |
5. Assess and measure function for HIV-related aging phenotypes and validate as predictors of relevant outcomes in HIV-infected populations. | |
Biological mechanisms
| 1. Identify clusters of risk factors for specific HIV-related aging phenotypes as potential targets for preventive or therapeutic strategies. |
2. Develop reliable biomarkers of HIV-related aging phenotypes and link biomarkers to clinical events including response to anti-inflammatory treatments and associated morphologic improvements. | |
3. Determine specific mechanism underlying chronic inflammation as predictors of HIV-related comorbid aging to potentially target these predictors (e.g., host genetic predictors) before AIDS comorbidities emerge. | |
4. Identify physiological vulnerabilities central to HIV-related aging phenotypes including poor response to stressors and mechanisms that underlie subclinical components. | |
5. Employ computational biology strategies (e.g., nonlinear methods) to address multiple interrelated physiological and molecular systems with clinical outcomes. | |
Targeted intervention
| 1. Improve understanding of epidemiologic contexts for HIV-related aging phenotype targeted interventions including accurate rates of testing, linkage, initiation and viral suppression that indicates gaps and targets for intervention; |
2. Enhance intervention research on multiple prevention messages fopr HIV-related aging phenotypes and expand with multilevel intervention strategies including individual, group, community, structural, and policy level strategies. | |
3. Analyze most effective components of integrated interventions (and which integrated interventions work best, for whom, and in what circumstances) within overlapping interacting HIV-related aging phenotypes and develop most promising, cost-effective integrated interventions. (using pathway modeling or other dynamic systems approaches); | |
4. Conduct predictor and moderator analyses to suggest ways in which older patients may be selected for different HIV interventions and suggest potential avenues for further development of the interventions for increasing their effectiveness within certain subgroups, identified by HIV-related aging phenotypes; | |
5. Examine each step of HIV care continuum in older adults to optimize the likelihood of viral suppression within certain subgroups, identified by individual or interacting HIV-related aging phenotypes. |